The Florida Medical Cannabis Conference and Exhibition will be held near Tampa on May 19-21. The Conference and Exhibition will be a premier forum for informing the public and private sectors of the economic and medical significance of medical cannabis cultivation, processing and delivery in Florida.
Jeffrey Friedland, author of "Marijuana: The World's Most Misunderstood Plant" will speak on "Learning from the Cannabis Industry's Successes and Challenges."
About the Florida Medical Cannabis Conference and Exhibition
The Florida Medical Cannabis Conference and Exhibition will provide a premier forum for informing the public and private sectors of the economic and medical significance of medical cannabis cultivation, processing and delivery in Florida.
Attendees will have excellent networking opportunities and a chance to visit with exhibitors to preview the newest advances in medical cannabis products and services.
The event will be held at the Saddlebrook Resort & Spa in Wesley Chapel, Florida, just north of Tampa on May 19-21.
Attendance at the Conference and Exhibition is beneficial for medical professionals, patients, and entrepreneurs who are interested in the medical cannabis industry.
Topics that will be discussed at the Conference and Exhibition will include:
Cannabinoid-based medicine and emerging therapies
Recommending Cannabis Medicine
Government Regulation and Policies
Banking & Tax Structuring
Cultivation, Processing, and Dispensing
Running a Medical Cannabis Business
Medical Cannabis Advocacy
For more information, or to register to attend, please visit: http://floridamedicalcannabisconference.com/
About Jeffrey Friedland
Jeffrey Friedland is an emerging market pioneer -- his firm, Friedland Capital, was one of the first American investment banks to establish a presence in China -- and he is now on the front lines of the global cannabis industry.
He is the author of “Marijuana: The World’s Most Misunderstood Plant” and is a founder and CEO of INTIVA Inc., which has businesses and investments in the cannabis industry in California, Colorado and Israel, and an investment in two licensed marijuana producers in Canada.
Friedland is also CEO of INTIVA BioPharma Inc., which is proceeding with pre-clinical and clinical drug development activities, in accordance with U.S. Food and Drug Administration (FDA) protocols, for a number of pharmaceutical formulations that include cannabinoids.
Friedland has been an owner of two recreational marijuana stores and a cultivation facility in Colorado. Friedland is also a director of Israel-based CannRX,. He is an adviser to Israel-based OWC Pharmaceutical Research (Stock Symbol: OWCP).